Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer (RADIT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by Hannover Medical School.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Novartis
Information provided by:
Hannover Medical School
ClinicalTrials.gov Identifier:
NCT01242631
First received: November 16, 2010
Last updated: June 21, 2011
Last verified: November 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)